Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Danaher Corp DHR.30


Primary Symbol: DHR

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.


NYSE:DHR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by zayaroy18on Jun 27, 2022 8:30am
199 Views
Post# 34784019

Autoimmune Disease Diagnosis Market Size, Share, Report 2026

Autoimmune Disease Diagnosis Market Size, Share, Report 2026

According to the latest report by IMARC Group, titled “Autoimmune Disease Diagnosis Market : Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026,” The global autoimmune disease diagnosis market size reached a value of US$ 4.4 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.1% during 2021-2026.

An autoimmune disease refers to a medical condition wherein the immune system attacks and destroys healthy cells, tissues, and organs of the body. It can also lead to abnormal growth and improper functioning of an organ. It can be effectively diagnosed using medical history, physical examination, blood tests, X-rays, and biopsy. Moreover, the overactive immune response is controlled through physical therapy, anti-inflammatory, immunosuppressant drugs, injections, and surgery.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Autoimmune Disease Diagnosis Market Trends:

Due to the rising prevalence of autoimmune disorders, healthcare professionalsacross the globe are financing research and development (R&D) activitiesto integrate technological advancements in conducting medical diagnoses with faster and more precise results. Besides this, diagnostic centers are launching public awareness campaigns to educate individuals about autoimmune diseases and their available diagnosis and treatments, which in turn, is creating a positive outlook for the market.In addition, favorable government policiesand increasing healthcare expenditure are anticipated to strengthen the growth of the market.

 

Request Free Sample Report: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/requestsample

Global Autoimmune Disease Diagnosis Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, Aesku.Diagnostics GmbH & Co. KG, Beckman Coulter Inc. (Danaher Corporation), bioMrieux SA (Institut Mrieux), Bio-Rad Laboratories Inc., Euroimmun AG (PerkinElmer Inc.), Hemagen Diagnostics Inc., Inova Diagnostics Inc. (Werfen Group S.A.), Myriad Genetics Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens AG), SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech, etc.

The report has segmented the market on the basis of product, disease, test, user and Region

Breakup by Product Type:

Consumables and Assay Kits
Instruments

Breakup by Disease Type:

Systemic Autoimmune Disease
Rheumatoid Arthritis
Psoriasis
Systemic Lupus Erythematosus (SLE)
Multiple Sclerosis
Others
Localized Autoimmune Disease
Inflammatory Bowel Disease
Type 1 Diabetes
Thyroid
Others

Breakup by Test Type:

Routine Laboratory Tests
Inflammatory Markers
Autoantibodies and Immunologic Tests
Others

Breakup by End-User:

Clinical Laboratories
Hospitals
Others

Breakup by Region:

North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 


<< Previous
Bullboard Posts
Next >>